Reumatología Clínica Reumatología Clínica
Reumatol Clin 2008;4 Supl 1:17-21 - Vol. 4 DOI: 10.1016/S1699-258X(08)76134-5
Enfermedades sistémicas autoinmunitarias
Comorbilidad en lupus eritematoso sistémico
Comorbidity of Systemic Lupus Erythematosus
Eduardo Úcar Angulo??, , Natalia Rivera García
Servicio de Reumatología. Hospital de Basurto. Bilbao. Vizcaya. España

Patients with systemic lupus erythematosus (SLE) suffer a series of incidence-associated pathologies more frequent than general population. Comorbility includes: infections, arteriosclerosis, coronary arteriopathy, osteoporosis, and avascular necrosis of the bone, to name the more frequent ones. In general, such complications are related, above all, to the degree of SLE activity and the dosages of daily and accumulated corticoids. It is a matter of highlighting the importance of the associated pathologies in regards to our patients’ prognosis and of taking them into consideration when we establish a treatment for our patients’ during each one of their visits.

Palabras clave
Lupus, Comorbilidad, Infección, Arteriosclerosis, Osteoporosis
Key words
Lupus, Comorbility, Infection, Arteriosclerosis, Osteoporosis
El Texto completo solo está disponible en PDF
D.D. Gladman,M.B. Urowitz
Morbidity in systemic lupus erythematosus
J Rheumatol, 14 (1987), pp. 223-226
M. Petri,S. Perez-Gutthann,J.C. Longenecker,M.C. Hochberg
Morbidity of systemic lupus erythematosus: Role of race and socioeconomic status
Ann J Med, 91 (1991), pp. 345-353
M. Petri,M. Genovese
Incidence of and risk factors for hospitalizations in systemic lupus erythematosus: a prospective study of the Hopkins Lupus Cohort
J Rheumatol, 19 (1992), pp. 1559-1565
F. Formiga Pérez,I. Moga Sampere,R. Canet González,M. Pac Ferraz,F. Mitjavila Villero,F. Fernández Nogués
Infection and systemic lupus erythematosus: analisis of a series of 145 patients
Rev Clin Esp, 193 (1993), pp. 105-109
F.J. Blanco,J.J. Gómez-Reino,J. De La Maza,A. Corrales,V. Rodriguez-Valverde,J.C. Rosas
Survival analysis of 306 European Spanish patients with systemic lupus erythematosus
Lupus, 7 (1998), pp. 159-163
R. Cervera,M.A. Khamashta,J. Font,G.D. Sebastiani,A. Gil,P. Lavilla,A.O. Aydintug
Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1.000 patients. European Working Party on Systemic Lupus Erythematosus
Medicine (Baltimore), 78 (1999), pp. 167-175
S. Rosner,E.M. Ginzler,H.S. Diamond,M. Weiner,M. Schlesinger,J.F. Fries
A multicenter study of outcome in systemic lupus erythematosus. II. Causes of death
Arthritis Rheum, 25 (1982), pp. 612-617
B. Holvast,A. Huckriede,C.G.M. Kallenberg,M. Bijl
Influenza vaccination in systemic lupus erythematosus: Safe and protective?
Autoimmun Rev, 6 (2007), pp. 300-305
M.B. Urowitz,D. Ibáñez,D.D. Gladman
Atherosclerotic vascular events in a single large lupus cohort: Prevalence and risk factors
J Rheumatol, 34 (2007), pp. 70-75
M.M. Ward
Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus
S. Manzi,F. Selzer,K. Sutton-Tyrrell,S.G. Fitzgerald,J.E. Rairie,R.P. Tracy
Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus
K.H. Leona,E.T. Koh,P.H. Fena,M.L. Boey
Lipid profiles in patients with systemic lupus erythematosus
J Rheumatol, 21 (1994), pp. 1264-1267
D.J. Wallace,A.L. Metzger,V.J. Stecher,B.A. Turnbull,P.A. Kern
Colesterol lowering effect of hydroxychloroquine in patients with rheumatic disease: Effects on lipid metabolism
Am J Med, 89 (1990), pp. 322-326
E.F. Borba,E. Bonfa
Longterm beneficial effect of chloroquine diphosphate on lipoprotein profile in lupus patients with and without steroid therapy
J Rheumatol, 28 (2001), pp. 780-785
A. Abou-Raya,S. Abou-Raya
Inflammation: A pivotal link between autoimmune diseases and atherosclerosis
Autoimmun Rev, 5 (2006), pp. 331-337
E. Krishnan
Stroke subtypes among young patients with systemic lupus erythematosus
Am J Med, 118 (2005), pp. e1-7
Y. Molad,N. Levin-Laina,M. Vaturi,J. Sulkes,A. Sagie
Herth valve calcification in young patients with systemic lupus erythematosus: A window to premature atherosclerotic vascular morbidity and risk factor for all-cause mortality
B.F. Mandell
Cardiovascular involvement in systemic lupus erythematosus
Semin Arthritis Rheum, 17 (1987), pp. 126-141
P.E. Lazzerini,P.L. Capecchi,F. Guideri,M. Acampa,M. Galeazzi,F. Laghi Pasini
Connective tissue diseases and cardiac rhythm disorders: An overview
Autoimmun Rev, 5 (2006), pp. 306-313
M. Abu-Shraka,M.B. Urowitz,D.D. Gladman,J. Gough
Mortality studies in systemic lupus erythematosus. Results from a single centre. I. Causes of death
J Rheumatol, 22 (1995), pp. 1259-1264
D. Fen,R.W. Keen
Osteoporosis in systemic lupus erythematosus: Prevalence and therapy
Lupus, 10 (2001), pp. 227-232
Y. Kipen,R. Buchbinder,A. Forbes,B. Strauss,G. Littlejohn,E. Morand
Prevalence of reduced bone mineral density in systemic lupus erythematosus and the role of steroids
J Rheumatol, 24 (2007), pp. 1922-1928
F. Formiga,I. Moga,J.M. Nolla,M. Pac,F. Mitjavila,D. Roig-Escofet
Loss of bone mineral density in premenopausal women with systemic lupus erythematosus
Ann Rheum Dis, 54 (1995), pp. 274-276
R. Ramsey-Goldman,S. Mamzi
Association of osteoporosis and cardiovascular disease in women with systemic lupus erythematosus
Arthritis Rheum, 44 (2001), pp. 2338-2341
S.C. Manalagas,R. Jilka
Bone marrow, cytokines and bone remodeling. Emerging insights into the patophysiology of osteoporosis
N Engl J Med, 332 (1995), pp. 303-311
E.E. Velayos,J.D. Leidholt,C.J. Smyth,R. Priest
Arthropathy associated with steroid therapy
Ann Intern Med, 64 (1966), pp. 759
P.L. Williams,M. Corbett
Avascular necrosis of bone complicating corticosteroid replacement therapy
Ann Rheum Dis, 42 (1983), pp. 276-279
M. Petri
Musculoskeletal complications of systemic lupus erythematosus in the Hopkins Lupus Cohort: An update
Arthritis Care Res, 8 (1995), pp. 137-145
E.L. Dubois,L. Cozen
Avascular (aseptic) bone necrosis associated with systemic lupus erythematosus
JAMA, 174 (1960), pp. 108
J.S. Sheik,G.S. Retzinger,H.V. Hess
Association of osteonecrosis in systemic lupus erythematosus with anormalities of fibrinolysis
Lupus, 7 (1998), pp. 42-48
M.A. Mont,C.J. Glueck,I.H. Pacheco,P. Wang,D.S. Hungerford,M. Petri
Risk factors for osteonecrosis in systemic lupus erythematosus
J Rheumatol, 24 (1997), pp. 654-662
D.A. Blueinke,M. Petri,E.A. Zerhouni
Femoral head perfusion and composition: MR imaging and spectroscopic evaluation of patients with systemic lupus erythematosus and at risk for avascular necrosis
G.S. Cooper,M.A. Dooley,E.L. Treadwell,E.W. St Clair,G.S. Gil Keson
Hormonal and reproductive risk factors for development of systemic lupus erythematosus: Results of a population-based, case-control study
Arthritis Rheum, 46 (2002), pp. 1830-1839
A. Zonana-Nacach,S. Barr,L. Magder,M. Petri
Damage in SLE and its association with prednisone [resumen]
Arthritis Rheum, 41 (1998), pp. S218
S. Bernatsky,J. Boivin,J. Rajan,A. Zoma,S. Manzi,E. Ginzler
An international cohort study of cancer in systemic lupus erythematosus
Arthritis Rheum, 52 (2005), pp. 1481-1490
J. Bin,S. Bernatsky,C. Gordon,J. Boivin,E. Ginzler,D. Gladman
Lung cancer in systemic lupus erythematosus
Lung Cancer, 56 (2007), pp. 303-306
L. Bjornadal,B. Lofstrom,L. Yin,I. Lundberg,A. Ekbom
Increased cancer incidence in a Swedish cohort of patients with systemic lupus erythematosus
Scand J Rheumatol, 31 (2002), pp. 66-71
J. Cibere,J. Sibley,M. Haga
Systemic lupus erythematosus and the risk of malignancy
Lupus, 10 (2001), pp. 394-400
J.F. Sequeiro,D. Cesic,G. Keser,M. Bukelica,S. Karanagnostis,M.A. Khamashtam
Allergic disorders in systemic lupus erythematosus
Allergol Immunol (Madr), 13 (1985), pp. 323-326
S. Gaucha,S. Hamzaoui,M. Abdallam,K. Bouslama,A. Harmel,M. Ennafaa
Association lupus érythémateux systémique et psoriasis. À propos d’une observation
J Rev Med, 26 (2005), pp. 431-433
F. Wolfe,H.A. Smythe,M.B. Yunus,R.M. Bennet,C. Bombardier,D.L. Goldenberg
The American College of Rheumatology 1990 criteria for the classification of fibromialgia: Report of the Multicentre Criteria Committee
Arthritis Rheum, 33 (1990), pp. 160-172
D.D. Gladman,M.B. Urowitz
Morbidity in systemic lupus erythematosus
J Rheumatol, 14 (1987), pp. 223-226
S. Manzi,E.N. Meilahn,J.E. Rairie,C. Conte,T.A. Medsger,L. Jansen-McWilliams
Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: Comparison with the Framingham Study
Am J Epidemiol, 145 (1997), pp. 408-415
M. Petri,S. Pérez-Gutthann,D. Spence,M.C. Hochberg
Risk factors for coronary artery disease in patients with systemic lupus erythematosus
Am J Med, 93 (1992), pp. 513-519
R. Cervera,on behalf of the members of the European Working Party on Systemic Lupus Erythematosus Systemic lupus erythematosus in Europe at the change of the millennium: Lessons from the “Euro-Lupus Proyect”
Autoimm Rev, 5 (2006), pp. 180-186
S. Bernatsky,J.F. Boivin,L. Joseph,S. Manzi,E. Ginzler,D.D. Gladman
Mortality in systemic lupus erythematosus
Arthritis Rheum, 54 (2006), pp. 2550-2557
Correspondencia: Dr. E. Úcar Angulo. Servicio de Reumatología. Hospital de Basurto. Avda. Montevideo, 18. 48013 Bilbao. Vizcaya. España.
Copyright © 2008. Elsevier Espa??a S.L. Barcelona
Reumatol Clin 2008;4 Supl 1:17-21 - Vol. 4 DOI: 10.1016/S1699-258X(08)76134-5